Back to search

France· FR:61276216

BIPRETERAX 5 mg/1,25 mg, comprimé pelliculé

A medicinal product containing indapamide + périndopril arginine, registered in France by LES LABORATOIRES SERVIER, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBIPRETERAX 5 mg/1,25 mg, comprimé pel…ATC—REGISTER NO.FR:61276216PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
INDAPAMIDE + PÉRINDOPRIL ARGININE
Manufacturer
LES LABORATOIRES SERVIER
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400937824057
    1 pilulier(s) polypropylène de 30 comprimé(s)
    EUR 3.64
  • cip13
    3400937824286
    3 pilulier(s) polypropylène de 30 comprimé(s)
    EUR 10.53

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Indapamide + périndopril arginine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indapamide + périndopril arginine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Bi Preterax Arginin, Preterax Arginin
  • Belgium · Coversyl Plus, Perindopril/Indapamide Krka
  • Bulgaria · Ко-Пренеса Нео, Нолипрел
  • Cyprus · Coversyl Plus Arginine, Preterax
  • Czechia · Prenewel Neo, Prestarium Neo Combi
  • Germany · Bipreterax N, Bipreterax N Forte
  • Denmark · Coversyl Comp Novum, Noliterax
  • Estonia · Co-Prenessaneo, Noliprel Arginine
  • Finland · Coversyl Comp Novum, Preterax Novum
  • United Kingdom (Northern Ireland) · Coversyl Arginine Plus
  • Greece · Co-Perineva, Preterax
  • Croatia · Perindoprilarginin/Indapamid Krka, Prexanil Combi A
  • Hungary · Co-Prenessa-As, Coverex-As Komb
  • Ireland · Coversyl Arginine Plus, Perindopril Arginine/Indapamide Tad
  • Italy · Noliterax, Perindopril E Indapamide Mylan
  • Lithuania · Noliprel, Noliprel Forte
  • Luxembourg · Coversyl Plus, Perindopril/Indapamide Viatris
  • Latvia · Noliprel Arginine, Noliprel Forte Arginine
  • Malta · Coversyl Plus
  • Netherlands · Coversyl Plus Arg, Perindopril Arginine/Indapamide Viatris
  • Poland · Coarprenessa, Noliprel
  • Portugal · Perindopril + Indapamida Anova, Perindopril + Indapamida Tad
  • Romania · Co-Prenessaneo, Noliprel Arg
  • Slovenia · Bionoliprel, Bioprexanil Combi
  • Slovakia · Co-Prenessa Neo, Noliprel A

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c74dd3f7-eae3-45df-a8e3-a0bb0261d4ed
GET /v1/drugs/c74dd3f7-eae3-45df-a8e3-a0bb0261d4ed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61276216",
  "date_amm": "2007-02-13",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "INDAPAMIDE + PÉRINDOPRIL ARGININE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about indapamide + périndopril arginine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.